Bangkok Genomics Innovation PCL

Bangkok Genomics Innovation PCL Goodwill

Goodwill of Bangkok Genomics Innovation PCL (BKGI.BK) as of Nov 13, 2026.

Goodwill

-THB

Last updated:

Goodwill of Bangkok Genomics Innovation PCL is 2026 - THB. Goodwill of Bangkok Genomics Innovation PCL was 2025 - THB. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bangkok Genomics Innovation PCL Stock analysis

What does Bangkok Genomics Innovation PCL do? Bangkok Genomics Innovation PCL offers the NIFTY test and clinical genomics services including COVID-19 RT-PCR Testing, BGI VISTA Carrier Screening, BGI NOVA Newborn Genetic Screening, BGI SENTIS Hereditary Cancer Screening, BGI’s Clinical Whole Exome Sequencing, and COLOTECT 3.0 Non-invasive Test for Colorectal Cancer Screening. The company serves healthcare providers and patients across North America, Europe, and Asia-Pacific through its global network of offices and laboratories. Bangkok Genomics Innovation Public Company Limited operates as a research and application center for genomics and bioinformatics, focusing on precision medicine development. Its services are delivered through established brands like BGI and COLOTECT 3.0, targeting medical institutions and individuals seeking advanced genetic testing solutions. The company generates revenue by providing specialized genomics and bioinformatics services under its own brand and through BGI and COLOTECT 3.0. Healthcare providers purchase these services for diagnostic and preventive care, while patients utilize the NIFTY test and other screening options directly or via healthcare partners. Bangkok Genomics Innovation PCL operates in the genomics sector with a focus on precision medicine applications, serving both clinical and research segments through its global infrastructure. Bangkok Genomics Innovation PCL’s business model centers on delivering high-value genomic testing services through established medical technology brands. The firm’s revenue streams come from clinical testing services including BGI VISTA Carrier Screening, BGI NOVA Newborn Genetic Screening, and COLOTECT 3.0, which are marketed to healthcare institutions and individual patients. The company’s global presence across North America, Europe, and Asia-Pacific enables it to serve diverse healthcare markets with its specialized offerings in genomics and precision medicine. Bangkok Genomics Innovation PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bangkok Genomics Innovation PCL stock

On Eulerpool you can find the complete historical development of Goodwill Bangkok Genomics Innovation PCL since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Bangkok Genomics Innovation PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bangkok Genomics Innovation PCL

All Key Metrics — Bangkok Genomics Innovation PCL